These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7818564)

  • 61. [Genetic polymorphisms of thiopurine methyltransferase and incidence of adverse events in patients with medical indication of azathioprine].
    Buhl MA; Gómez G; Collado MV; Oddo EM; Khoury M; Azurmendi PJ; Sarano J
    Medicina (B Aires); 2018; 78(2):65-70. PubMed ID: 29659353
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bone marrow inhibition induced by azathioprine in a patient without mutation in the thiopurine S-methyltransferase pathogenic site: A case report.
    Zhou XS; Lu YY; Gao YF; Shao W; Yao J
    World J Clin Cases; 2021 Jun; 9(17):4230-4237. PubMed ID: 34141785
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Predictors of azathioprine toxicity in children with autoimmune hepatitis.
    Behairy BE; El-Said HH; Konswa HA; El-Deen AEN; Adawy NM; Sira AM
    Clin Exp Hepatol; 2021 Mar; 7(1):47-54. PubMed ID: 34027115
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Recombinogenic, genotoxic, and cytotoxic effects of azathioprine using
    Melo Bisneto AVD; Oliveira LCD; Silva Fernandes A; Silva LS; Véras JH; Cardoso CG; E Silva CR; de Moraes Filho AV; Carneiro CC; Chen-Chen L
    J Toxicol Environ Health A; 2021 Mar; 84(6):261-271. PubMed ID: 33372579
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preliminary results with azathioprine treatment in rheumatoid arthritis.
    Swannell AJ; Kersley GD
    Ann Phys Med; 1969 Nov; 10(4):163-6. PubMed ID: 5349272
    [No Abstract]   [Full Text] [Related]  

  • 66. Effects on bone marrow cells of oral treatment with podophyllotoxin derivatives in rheumatoid arthritis.
    Norberg B; Berglund K; Edström UB; Rydgren L; Sturfeldt G
    Scand J Rheumatol; 1985; 14(3):271-5. PubMed ID: 4048874
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Azathioprine-Induced Marrow Suppression in Dermatology Patients - Analysis of 18 Patients.
    Saoji VV; Jawade SA; Agrawal P; Rimmalapudi S
    Indian J Dermatol; 2022; 67(1):50-53. PubMed ID: 35656241
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease.
    Perrotta F; Sanduzzi Zamparelli S; D'Agnano V; Montella A; Fomez R; Pagliaro R; Schiattarella A; Cazzola M; Bianco A; Mariniello DF
    Biomedicines; 2024 Jun; 12(7):. PubMed ID: 39061958
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacogenetics of Drug Therapies in Rheumatoid Arthritis.
    Aluko A; Ranganathan P
    Methods Mol Biol; 2022; 2547():527-567. PubMed ID: 36068476
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Assessment of Thiopurine-based drugs according to Thiopurine S-methyltransferase genotype in patients with Acute Lymphoblastic Leukemia.
    Azimi F; Jafariyan M; Khatami S; Mortazavi Y; Azad M
    Iran J Ped Hematol Oncol; 2014; 4(1):32-8. PubMed ID: 24734162
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Genetic polymorphisms of NQO1, CYP1A1 and TPMT and susceptibility to acute lymphoblastic leukemia in a Tunisian population.
    Ouerhani S; Cherif N; Bahri I; Safra I; Menif S; Abbes S
    Mol Biol Rep; 2013 Feb; 40(2):1307-14. PubMed ID: 23065291
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacogenetics: implications for therapy in rheumatic diseases.
    Davila L; Ranganathan P
    Nat Rev Rheumatol; 2011 Aug; 7(9):537-50. PubMed ID: 21826093
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The haemotoxicity of azathioprine in repeat dose studies in the female CD-1 mouse.
    Molyneux G; Gibson FM; Chen CM; Marway HK; McKeag S; Mifsud CV; Pilling AM; Whayman MJ; Turton JA
    Int J Exp Pathol; 2008 Apr; 89(2):138-58. PubMed ID: 18336531
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Purine enzymes in patients with rheumatoid arthritis treated with methotrexate.
    van Ede AE; Laan RF; De Abreu RA; Stegeman AB; van de Putte LB
    Ann Rheum Dis; 2002 Dec; 61(12):1060-4. PubMed ID: 12429535
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The use of therapeutic drug monitoring to optimise immunosuppressive therapy.
    Tsunoda SM; Aweeka FT
    Clin Pharmacokinet; 1996 Feb; 30(2):107-40. PubMed ID: 8906895
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Azathioprine-related bone marrow toxicity and low activities of purine enzymes in patients with rheumatoid arthritis.
    Kerstens PJ; Stolk JN; De Abreu RA; Lambooy LH; van de Putte LB; Boerbooms AA
    Arthritis Rheum; 1995 Jan; 38(1):142-5. PubMed ID: 7818564
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Purine enzymes in rheumatoid arthritis: possible association with response to azathioprine. A pilot study.
    Kerstens PJ; Stolk JN; Boerbooms AM; Lambooy LH; de Graaf R; De Abreu RA; van de Putte LB
    Ann Rheum Dis; 1994 Sep; 53(9):608-11. PubMed ID: 7979599
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reduced thiopurine methyltransferase activity and development of side effects of azathioprine treatment in patients with rheumatoid arthritis.
    Stolk JN; Boerbooms AM; de Abreu RA; de Koning DG; van Beusekom HJ; Muller WH; van de Putte LB
    Arthritis Rheum; 1998 Oct; 41(10):1858-66. PubMed ID: 9778228
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Purine enzyme activities in recent onset rheumatoid arthritis: are there differences between patients and healthy controls?
    Stolk JN; Boerbooms AM; De Abreu RA; Kerstens PJ; de Koning DG; de Graaf R; Mulder J; van de Putte LB
    Ann Rheum Dis; 1996 Oct; 55(10):733-8. PubMed ID: 8984938
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.